Magdalena Wilga is currently a Doctoral Researcher at the Institute of Biochemistry and Biophysics PAS, focusing on identifying epigenetic mechanisms in clear cell renal cell carcinoma. Prior to this, Magdalena worked at AstraZeneca as a Global Study Associate, contributing to clinical study start-up, execution, and close-out. Magdalena also has experience in study management and operations, as well as internships in various pharmaceutical companies. Magdalena holds a Master's degree in Pharmacy from the Medical University of Warsaw.
This person is not in any offices